Case report: Relapsed disseminated cutaneous herpes zoster successfully treated with brivudine

IF 0.7 4区医学

European Journal of Inflammation Pub Date : 2023-10-20 DOI:10.1177/1721727x231209827

Mengdi Feng, Jinfang Zhang, Guoqiang Zhang

引用次数: 0

Abstract

A 64-year-old man presented with painful rash on the trunk and extremities for more than half a month. Nephrotic syndrome had been diagnosed 2 years ago and had been regularly treated with glucocorticoids and immunosuppressants. He developed herpes zoster 1 year ago. Laboratory investigation demonstrated varicella-zoster virus DNA (VZV-DNA), varicella-zoster virus IgM (VZV-IgM), and varicella-zoster virus antibody IgG (VZV-IgG) were all positive. After the clinical diagnosis of relapsed disseminated cutaneous herpes zoster had been confirmed, systemic therapy with brivudine 125 mg everyday was started.

查看原文本刊更多论文

病例报告:布夫定成功治疗复发性播散性皮肤带状疱疹

64岁男性，躯干和四肢出现疼痛皮疹半个多月。2年前诊断出肾病综合征，并定期接受糖皮质激素和免疫抑制剂治疗。他一年前得了带状疱疹。水痘-带状疱疹病毒DNA (VZV-DNA)、水痘-带状疱疹病毒IgM (VZV-IgM)和水痘-带状疱疹病毒抗体IgG (VZV-IgG)均呈阳性。经临床诊断为复发性弥散性皮肤带状疱疹后，开始布里夫定125 mg / d的全身治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Journal of Inflammation Medicine-Immunology and Allergy

自引率

0.00%

发文量

期刊介绍： European Journal of Inflammation is a multidisciplinary, peer-reviewed, open access journal covering a wide range of topics in inflammation, including immunology, pathology, pharmacology and related general experimental and clinical research.